Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts) with biochemically recurrent prostate cancer (PCa): A phase III study (CONDOR)-A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth.
PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients (pts) with biochemically recurrent prostate cancer (PCa): A phase III study (CONDOR)-A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth. Pouliot, F., Gorin, M. A., Rowe, S. P., Saperstein, L., Josephson, D., Carroll, P. R., Wong, J. C., Pantel, A. R., Cho, S. Y., Gage, K. L., Piert, M., Iagaru, A., Pollard, J. H., Wong, V., Jensen, J., Stambler, N., Morris, M. J., Siegel, B. A. LIPPINCOTT WILLIAMS & WILKINS. 2021View details for DOI 10.1200/JCO.2021.39.6_suppl.33
View details for Web of Science ID 000636801500084